Rare diseases
Investigational molecules
Locations
Back to Belgium1 305 clinical trials in Charleroi, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Colchicine for Patients with Coronary Artery Disease After Percutaneous Coronary Intervention
BelgiumStudy on High-Risk Prostate Cancer Treatment Using Darolutamide, Relugolix, and Drug Combination for Eligible Patients
BelgiumStudy Comparing Thymoglobulin and Grafalon for Preventing Graft Versus Host Disease in Elderly Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome
BelgiumStudy on the Long-term Safety and Tolerability of Azetukalner for Patients with Epilepsy, Including Focal-onset and Primary Generalized Tonic-Clonic Seizures
BelgiumStudy on the Effectiveness of Belumosudil and Azithromycin for Adults with Chronic Lung Rejection After Lung Transplant
BelgiumStudy on Long-Term Safety of Inhaled Treprostinil for Patients with Fibrotic Lung Disease
BelgiumLong-term Study of Ibrutinib for Patients with B-cell Non-Hodgkin's Lymphoma and Chronic Graft Versus Host Disease
BelgiumStudy on Monitoring vs. Rivaroxaban for Patients with Low-Risk Isolated Subsegmental Pulmonary Embolism
BelgiumStudy on Treating Acute Myeloid Leukemia in Children and Adolescents Using Gemtuzumab Ozogamicin and a Drug Combination
BelgiumStudy on Conditioning Treatments with Busulfan, Clofarabine, and Fludarabine for Children with Acute Myeloid Leukemia Undergoing Stem Cell Transplantation
BelgiumStudy on Elacestrant for Treating ER+/HER2- Breast Cancer in Patients with ctDNA Relapse
BelgiumBelgiumThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, particularly in breast cancer, lung cancer, and head and neck cancers. Studies evaluate novel therapeutic approaches including immunotherapy combinations and targeted treatments.
Multiple trials investigating personalized medicine approaches and biomarker-driven treatments.
Research examining treatments for coronary artery disease and post-cardiac arrest care. Trials focus on innovative stent technologies and antiplatelet therapy optimization.
Emphasis on improving patient outcomes through targeted interventional approaches.
Clinical investigations targeting inflammatory skin conditions and immune-mediated disorders. Studies evaluate novel treatments for psoriasis and other dermatological conditions.
Focus on developing targeted therapies for chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
